Minimally-Invasive Glaucoma Surgery, also known as MIGS, refers to one of a number of glaucoma surgical treatments aimed at either reducing eye pressure, reducing dependence on glaucoma medication or both. The MIGS procedures work by increasing the rate that fluid within the eye
drains out, which in turn results in a lowering in intra-ocular pressure. They are usually quick procedures to perform, have a very good safety profile and a rapid recovery. This offers a distinct advantage over traditional glaucoma surgeries which take longer, are associated with more serious complications and have a slower recovery.
The MIGS currently available for use in Australia are Glaukos iStent and inStent inject. Both the Ivantis Hydrus and Allergan XEN implant are currently available on restricted access. We are expecting the Alcon Cypass to become available later this year. For more information, please see the following links: